Investing Ideas
/
Canadian Pharmaceuticals & Biotech Sustainable Track Record

Canadian Pharmaceuticals & Biotech Sustainable Track Record

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.

1 companies

BioSyent

Market Cap: CA$136.7m

Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.

CA$11.95

10.1%

5.3%